Allogeneic mesenchymal stromal cell (MSC) therapy for patients with focal knee cartilage defects — umbilical‑cord‑derived MSCs expanded for defect coverage, potential hyaline cartilage regeneration, and anti‑inflammatory/analgesic effects.